Early trials for a vaccine to prevent dengue infections, responsible for more than 5 million cases and 5,000 deaths in 2023, are underway and showing success, according to data published Feb. 1 in The New England Journal of Medicine.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
